Tan Yann Chong
Chief Executive Officer at Nuevocor Pte Ltd.
Tan Yann Chong active positions
| Companies | Position | Start | End |
|---|---|---|---|
Nuevocor Pte Ltd.
 Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Chief Executive Officer | - | - |
| Founder | - | - |
Career history of Tan Yann Chong
Former positions of Tan Yann Chong
| Companies | Position | Start | End |
|---|---|---|---|
Esco Ventures Pte Ltd.
 Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Private Equity Investor | - | 31/07/2022 |
Training of Tan Yann Chong
| Stanford University | Graduate Degree |
| Duke University | Undergraduate Degree |
Statistics
International
| Singapore | 3 |
| United States | 3 |
Operational
| Private Equity Investor | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Esco Ventures Pte Ltd.
Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Finance |
Nuevocor Pte Ltd.
Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Tan Yann Chong
- Experience